Elucidata Company Research Report

Company Overview

• Name: Elucidata

• Mission: Empowering life science organizations with solutions for improving lives by making biomedical data AI-ready, unlocking actionable insights with scalable solutions.

• Founded: No information is available

• Founders: No information is available

• Key People:

• Abhishek Jha - Co-Founder, CEO

• Swetabh Pathak - Co-Founder, CTO

• Manimala Sen - Director, Technical Product Management

• Harshveer Singh - Director of Engineering, Research & Development

• Abhinav Sinha - Director, Solutions

• Drabir Ghosh - Associate Director, Strategy and Operations

• Headquarters: Cambridge, MA, United States with additional offices in San Francisco, New Delhi, and Bengaluru.

• Number of Employees: No information is available

• Revenue: No information is available

• Core Competency: Elucidata is known for their platform Polly, an AI-ready data platform that streamlines complex workflows, increases productivity, and provides reusable, findable, and AI-ready Data Products for end-to-end decision support.

Products

• Polly: The AI-Ready Data Platform

• Description: Polly is designed to streamline multimodal data integration, accelerate drug discovery and development, and derive actionable insights with a scalable, AI-powered platform.

• Key Features:

• Integrated Data Management: Unifies EHRs, omics, imaging, and clinical trial data in a single platform; LLM-powered metadata extraction.

• Scalable Infrastructure: Supports 26+ data types and 30+ bioinformatics pipelines.

• AI-Driven Insights: Offers AI-assisted cohort builders and dashboards for decision-making, predictive modeling, and visualizations for treatment recommendations.

Recent Developments

• Innovations and Recognitions:

• Recognized as 'Most Innovative Company in Biotech, 2024' by Fast Company.

• First place winners in the NCI-CRDC AI Data Readiness Challenge.

• Funding:

• Raised $16 million in a Series A funding round led by Eight Roads Ventures.

• Partnerships:

• Joined the Tetra Partner Network to enhance machine learning initiatives in life sciences.

• Product Enhancements:

• Introduction of a feature update: Disease and Tissue Ontology Recommendations on Polly.

• Implementation of novel tools for enhancing data findability and quality.

Conclusion

Elucidata stands as a pioneer in the biotech industry, recognized for its innovation and contributions to biomedical data readiness through its groundbreaking platform, Polly. With a strong leadership team and strategic partnerships, Elucidata continues to drive the industry forward by accelerating drug discovery and improving decision-making through AI-ready solutions.